Literature DB >> 25212320

Preparative purification of bromelain (EC 3.4.22.33) from pineapple fruit by high-speed counter-current chromatography using a reverse-micelle solvent system.

Lianhong Yin1, C K Sun2, Xu Han1, Lina Xu1, Youwei Xu1, Yan Qi1, Jinyong Peng3.   

Abstract

The crude protein of pineapple fruit was purified by high-speed counter-current chromatography (HSCCC). Excellent separation was achieved after careful investigation as follows: cetyltrimethylammonium bromide (CTAB) was selected to prepare the reverse micelle phase at the concentration of 0.10g/mL. The mobile phase was 0.05M sodium phosphate buffer solution, including mobile phase A (pH 9.5, containing 0.2M KCl) used for equilibration and mobile phase B (pH 7.0, containing 0.4M KCl) used for elution. The flow rate of the mobile phase was set at 1.5mL/min and the effluent was monitored at 280nm. Under these conditions, 127.3mg bromelain (EC 3.4.22.33) was produced from 200mg crude sample. A large-scale procedure was then carried out, and 3.01g bromelain was obtained from 5.00g crude extract in a 200min run. The separated protein was analysed by SDS-PAGE, compared with the standard and then identified by TOF/TOF-MS.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bromelain; CTAB; HSCCC; Protein separation and purification; Reverse micelle

Year:  2011        PMID: 25212320     DOI: 10.1016/j.foodchem.2011.05.048

Source DB:  PubMed          Journal:  Food Chem        ISSN: 0308-8146            Impact factor:   7.514


  2 in total

1.  Inhibition of Epithelial TNF-α Receptors by Purified Fruit Bromelain Ameliorates Intestinal Inflammation and Barrier Dysfunction in Colitis.

Authors:  Zijuan Zhou; Liang Wang; Panpan Feng; Lianhong Yin; Chen Wang; Shengxu Zhi; Jianyi Dong; Jingyu Wang; Yuan Lin; Dapeng Chen; Yongjian Xiong; Jinyong Peng
Journal:  Front Immunol       Date:  2017-11-10       Impact factor: 7.561

Review 2.  Bromelain and Nisin: The Natural Antimicrobials with High Potential in Biomedicine.

Authors:  Urška Jančič; Selestina Gorgieva
Journal:  Pharmaceutics       Date:  2021-12-29       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.